Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Spironolactone to Prevent Cardiovascular Events in Early Stage Chronic Kidney Disease (CKD): A Pilot Trial
2012-000654-55Phase 4Terminated
- Sponsor
- University of Birmingham
- Start
- May 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of spironolactone in chronic kidney disease (CKD), cardiac morbidity, sponsored by University of Birmingham. Started May 2012; status: terminated.
02
Drugs
spironolactone
03
Conditions
chronic kidney disease (CKD)cardiac morbidity
Beyond the preview
Go deeper on 2012-000654-55.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2012-000654-55.